AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24336948 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacemaker therapy in patients with negative tilt test (TT-), 26 patients
Number of subjects: 136
Study 24336948 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacemaker therapy in patients with positive tilt test (TT+), 26 patients
Number of subjects: 136
Study 24336948 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated patients), 45 patients
Number of subjects: 136
Study 22434182 — intervention group
Group type: EXPERIMENTAL
Intervention: β‐alanine (BA)
Number of subjects: 36
Study 22434182 — intervention group
Group type: COMPARATOR
Intervention: maltodextrin (MD)
Number of subjects: 36
Study 19958342 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure support ventilation
Number of subjects: 68
Study 19958342 — intervention group
Group type: COMPARATOR
Intervention: Pressure controlled ventilation
Number of subjects: 68
Study 17353402 — intervention group
Group type: EXPERIMENTAL
Intervention: Indocyanine green (ICG) solution
Number of subjects: 40
Study 17353402 — intervention group
Group type: EXPERIMENTAL
Intervention: Trypan blue (TB)
Number of subjects: 40
Study 17353402 — intervention group
Group type: COMPARATOR
Intervention: Both ICG and TB
Number of subjects: 40
Study 15475124 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise
Number of subjects: 18
Study 15475124 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric exercise
Number of subjects: 18
Study 15475124 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 18
Study 11528550 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone treatment with initial leukaemic blood blast count < 1000 blasts/microliter
Number of subjects: 660
Study 11528550 — intervention group
Group type: COMPARATOR
Intervention: Prednisone treatment with initial leukaemic blood blast count >= 1000 blasts/microliter
Number of subjects: 660
Study 11528550 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with < 1000 blasts/microliter on day eight of treatment but increasing blast count
Number of subjects: 660
Study 9989332 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based, self-contained nutrition education program (PCAT program)
Number of subjects: 263
Study 9989332 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary counseling with a registered dietician
Number of subjects: 263
Study 9989332 — intervention group
Group type: COMPARATOR
Intervention: At-risk control group
Number of subjects: 263
Study 9989332 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education interventions (general)
Number of subjects: 263
Study 9989332 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental dietary control
Number of subjects: 263
Study 7607785 — intervention group
Group type: EXPERIMENTAL
Intervention: Mazindol (0.5 mg, three tablets per day for three months)
Number of subjects: 36
Study 7607785 — intervention group
Group type: COMPARATOR
Intervention: Placebo (three tablets per day for three months)
Number of subjects: 36
Study 3125352 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium Chain Triglyceride/Long Chain Triglyceride (MCT/LCT) emulsion
Number of subjects: 10
Study 3125352 — intervention group
Group type: COMPARATOR
Intervention: Conventional Long Chain Triglyceride (LCT)
Number of subjects: 10
Study 29739354 — intervention group
Group type: EXPERIMENTAL
Intervention: Icodextrin solution (ICO)
Number of subjects: 43
Study 29739354 — intervention group
Group type: COMPARATOR
Intervention: Glucose-based solution (GLU)
Number of subjects: 43
Study 26513335 — intervention group
Group type: EXPERIMENTAL
Intervention: On-road motorcycle rider coaching program (4h riding and facilitated discussion)
Number of subjects: 2399
Study 26513335 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 2399
Study 24373856 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver diamine fluoride (SDF) applied biannually for 24 months
Number of subjects: 12
Study 24373856 — intervention group
Group type: COMPARATOR
Intervention: No topical fluoride treatment (active caries)
Number of subjects: 12
Study 23593205 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium thiosulfate (STS) 10 mmol twice a day for 7 days
Number of subjects: 10
Study 20598745 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based educational intervention
Number of subjects: 106
Study 20598745 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 106
Study 19052406 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol 0.005% ointment applied twice daily
Number of subjects: 20
Study 19052406 — intervention group
Group type: COMPARATOR
Intervention: Tazarotene 0.05% gel applied once daily
Number of subjects: 20
Study 19052406 — intervention group
Group type: COMPARATOR
Intervention: Tazarotene 0.1% gel applied once daily
Number of subjects: 20
Study 16889629 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified sonic scaler system
Number of subjects: 20
Study 16889629 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing (S/RP) with hand instruments
Number of subjects: 20
Study 16889629 — intervention group
Group type: COMPARATOR
Intervention: S/RP
Number of subjects: 20
Study 14994963 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin gastrointestinal therapeutic system (doxazosin-GITS)
Number of subjects: 0
Study 14994963 — intervention group
Group type: COMPARATOR
Intervention: Tamsulosin
Number of subjects: 0
Study 11673585 — intervention group
Group type: EXPERIMENTAL
Intervention: 8.0 mg albuterol twice daily
Number of subjects: 90
Study 11673585 — intervention group
Group type: EXPERIMENTAL
Intervention: 16.0 mg albuterol twice daily
Number of subjects: 90
Study 11673585 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 9779523 — intervention group
Group type: EXPERIMENTAL
Intervention: DigiTrace Home Sleep System (DHSS)
Number of subjects: 93
Study 7880766 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic tracheostomy weaning procedure
Number of subjects: 30
Study 7880766 — intervention group
Group type: COMPARATOR
Intervention: Random tracheostomy weaning procedure
Number of subjects: 30
Study 3278581 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (100 mg twice daily)
Number of subjects: 301
Study 3278581 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study 3278581 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 301
Study 3278581 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal accomplished workload at 6 weeks
Number of subjects: 301
Study 3278581 — intervention group
Group type: EXPERIMENTAL
Intervention: Male sex
Number of subjects: 301
Study 3278581 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous AMI
Number of subjects: 301
Study 3278581 — intervention group
Group type: EXPERIMENTAL
Intervention: Left ventricular failure
Number of subjects: 301
Study 3278581 — intervention group
Group type: COMPARATOR
Intervention: Exercise-induced ST-depression (≥ 1 mm) in placebo-treated patients
Number of subjects: 301
Study 30877066 — intervention group
Group type: EXPERIMENTAL
Intervention: Lycium barbarum (LB) supplement
Number of subjects: 42
Study 30877066 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 28667224 — intervention group
Group type: EXPERIMENTAL
Intervention: GAS method (gather-analyse-summarise)
Number of subjects: 35
Study 28667224 — intervention group
Group type: EXPERIMENTAL
Intervention: TeamTAG (teamwork techniques analysis grid)
Number of subjects: 35
Study 25358449 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Dietary Counseling (EDC)
Number of subjects: 47
Study 25358449 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care Dietary Counseling (SDC)
Number of subjects: 47
Study 24128861 — intervention group
Group type: EXPERIMENTAL
Intervention: Fludarabine plus cyclophosphamide (FC) chemotherapy
Number of subjects: 455
Study 24128861 — intervention group
Group type: COMPARATOR
Intervention: Chlorambucil
Number of subjects: 455
Study 24128861 — intervention group
Group type: COMPARATOR
Intervention: Fludarabine
Number of subjects: 455
Study 22506139 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror therapy and NMES
Number of subjects: 60
Study 22506139 — intervention group
Group type: COMPARATOR
Intervention: NMES only
Number of subjects: 60
Study 22506139 — intervention group
Group type: COMPARATOR
Intervention: Mirror therapy only
Number of subjects: 60
Study 19692530 — intervention group
Group type: EXPERIMENTAL
Intervention: Tart cherry juice (240 mL twice daily for 14 days)
Number of subjects: 12
Study 19692530 — intervention group
Group type: COMPARATOR
Intervention: Placebo (240 mL twice daily for 14 days)
Number of subjects: 12
Study 16508640 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOP (cyclophosphamide 750 mg/m², doxorubicin 50 mg/m², vincristine 1.4 mg/m², prednisolone 100 mg)
Number of subjects: 0
Study 16508640 — intervention group
Group type: COMPARATOR
Intervention: PMitCEBO (mitoxantrone 7 mg/m², cyclophosphamide 300 mg/m², etoposide 150 mg/m², vincristine 1.4 mg/m², bleomycin 10 mg/m², prednisolone 50 mg)
Number of subjects: 0
Study 16508640 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF
Number of subjects: 0
Study 16508640 — intervention group
Group type: COMPARATOR
Intervention: No G-CSF
Number of subjects: 0
Study 16508640 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOP
Number of subjects: 0
Study 16508640 — intervention group
Group type: COMPARATOR
Intervention: PMitCEBO
Number of subjects: 0
Study 14631835 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous intracerebral hemorrhage (SIHP) group
Number of subjects: 500
Study 11020593 — intervention group
Group type: EXPERIMENTAL
Intervention: STD counseling interventions (Project RESPECT)
Number of subjects: 3498
Study 11020593 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline misconceptions (e.g., washing genitals after sex, urinating after sex, douching, use of oral contraceptives)
Number of subjects: 3498
Study 11020593 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent misconceptions
Number of subjects: 3498
Study 9068812 — intervention group
Group type: EXPERIMENTAL
Intervention: Killed Mycobacterium vaccae as immunotherapy
Number of subjects: 206
Study 9068812 — intervention group
Group type: COMPARATOR
Intervention: Saline as placebo (control)
Number of subjects: 206
Study 8436780 — intervention group
Group type: EXPERIMENTAL
Intervention: Elimination diets
Number of subjects: 0
Study 8436780 — intervention group
Group type: COMPARATOR
Intervention: Nonatopic control subjects
Number of subjects: 0
Study 3096133 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin ointment (12.5 to 50 mg) applied to the arm
Number of subjects: 9
Study 3096133 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin ointment (12.5 to 50 mg) applied to the chest
Number of subjects: 9
Study 3096133 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin ointment (12.5 to 50 mg) applied to the thigh
Number of subjects: 9
Study 30088145 — intervention group
Group type: EXPERIMENTAL
Intervention: SURE (Strength for U in Relationship Empowerment) intervention
Number of subjects: 53
Study 30088145 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 53
Study 28768165 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated plasma mannose levels
Number of subjects: 0
Study 28768165 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 26184986 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based self-management intervention (12 hours of group education sessions, integrated counseling, and behavioral coaching)
Number of subjects: 250
Study 26184986 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based self-management intervention
Number of subjects: 250
Study 26184986 — intervention group
Group type: COMPARATOR
Intervention: Control group (waitlist)
Number of subjects: 250
Study 25236509 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG
Number of subjects: 1850
Study 25236509 — intervention group
Group type: COMPARATOR
Intervention: PCI/DES
Number of subjects: 1850
Study 21851019 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast Track Surgery (FTS) program
Number of subjects: 44
Study 21851019 — intervention group
Group type: COMPARATOR
Intervention: Traditional postoperative mode (Control)
Number of subjects: 44
Study 19675365 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate alcohol dose
Number of subjects: 413
Study 19675365 — intervention group
Group type: COMPARATOR
Intervention: Nonalcoholic beverage
Number of subjects: 413
Study 19675365 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 413
Study 19675365 — intervention group
Group type: EXPERIMENTAL
Intervention: Low alcohol dose
Number of subjects: 413
Study 19675365 — intervention group
Group type: EXPERIMENTAL
Intervention: High alcohol dose
Number of subjects: 413
Study 19675365 — intervention group
Group type: EXPERIMENTAL
Intervention: Established relationship
Number of subjects: 413
Study 17343006 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructus Bruceae oil emulsion (FBE) combined with chemotherapy (GP regimen)
Number of subjects: 115
Study 17343006 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (GP regimen) only
Number of subjects: 115
Study 15295219 — intervention group
Group type: COMPARATOR
Intervention: Palivizumab 5 mg/kg
Number of subjects: 59
Study 15295219 — intervention group
Group type: COMPARATOR
Intervention: Palivizumab 15 mg/kg
Number of subjects: 59
Study 15295219 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 11805893 — intervention group
Group type: EXPERIMENTAL
Intervention: Suction drains
Number of subjects: 100
Study 11805893 — intervention group
Group type: COMPARATOR
Intervention: No suction drains
Number of subjects: 100
Study 9568783 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary calcium intake (fifth quintile)
Number of subjects: 0
Study 9568783 — intervention group
Group type: COMPARATOR
Intervention: Calcium supplements
Number of subjects: 0
Study 8113835 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone marrow transplantation (BMT)
Number of subjects: 78
Study 8113835 — intervention group
Group type: COMPARATOR
Intervention: Intensive chemotherapy
Number of subjects: 78
Study 3382595 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide with oral controlled release morphine
Number of subjects: 20
Study 3382595 — intervention group
Group type: COMPARATOR
Intervention: Oral controlled release morphine alone
Number of subjects: 20
Study 30900194 — intervention group
Group type: EXPERIMENTAL
Intervention: Animal Assisted Therapy (AAT) with dogs
Number of subjects: 53
Study 30900194 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 53
Study 30733800 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS (1.5 mA, 20 min)
Number of subjects: 8
Study 30733800 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 8
Study 28544071 — intervention group
Group type: EXPERIMENTAL
Intervention: Perineal hydrodissection (HD)
Number of subjects: 21
Study 28544071 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (ST)
Number of subjects: 21
Study 26594989 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed inferior alveolar nerve block technique
Number of subjects: 29
Study 26594989 — intervention group
Group type: COMPARATOR
Intervention: Conventional inferior alveolar nerve block technique
Number of subjects: 29
Study 26594989 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 29
Study 22964343 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate Intervention Group (IIG) - Relaxation therapy days 3-6
Number of subjects: 18
Study 22964343 — intervention group
Group type: COMPARATOR
Intervention: Delayed Intervention Group (DIG) - Relaxation therapy days 6-9
Number of subjects: 18
Study 21361811 — intervention group
Group type: EXPERIMENTAL
Intervention: High call completion during the maintenance-enhancement phase
Number of subjects: 228
Study 20205023 — intervention group
Group type: EXPERIMENTAL
Intervention: Index of Self‐Regulation of Emotion (ISE)
Number of subjects: 0
Study 20205023 — intervention group
Group type: COMPARATOR
Intervention: Miller Behavioural Style Scale (MBSS)
Number of subjects: 0
Study 20205023 — intervention group
Group type: COMPARATOR
Intervention: Mainz Coping Inventory (MCI)
Number of subjects: 0
Study 17404163 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine (15 mg)
Number of subjects: 171
Study 17404163 — intervention group
Group type: COMPARATOR
Intervention: Felodipine 5 mg/ramipril 5 mg
Number of subjects: 171
Study 17404163 — intervention group
Group type: COMPARATOR
Intervention: Verapamil 180 mg/trandolapril 2 mg
Number of subjects: 171
Study 17404163 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol succinate 95 mg/hydrochlorothiazide 12.5 mg
Number of subjects: 171
Study 15381950 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetal pulse oximetry combined with acid-base equilibrium (ABE) monitoring
Number of subjects: 160
Study 15381950 — intervention group
Group type: COMPARATOR
Intervention: Control group with only acid-base equilibrium (ABE) monitoring
Number of subjects: 160
Study 15026090 — intervention group
Group type: EXPERIMENTAL
Intervention: Williams syndrome (WS) group
Number of subjects: 0
Study 15026090 — intervention group
Group type: COMPARATOR
Intervention: Prader-Willi syndrome (PWS) group
Number of subjects: 0
Study 15026090 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescents
Number of subjects: 0
Study 15026090 — intervention group
Group type: EXPERIMENTAL
Intervention: Adults
Number of subjects: 0
Study 10426833 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (24-week program)
Number of subjects: 51
Study 10426833 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 51
Study 7554709 — intervention group
Group type: EXPERIMENTAL
Intervention: Mofegiline (single oral doses up to 48 mg)
Number of subjects: 0
Study 7554709 — intervention group
Group type: EXPERIMENTAL
Intervention: Mofegiline (daily doses for 28 days up to 24 mg)
Number of subjects: 0
Study 7554709 — intervention group
Group type: EXPERIMENTAL
Intervention: Mofegiline (doses up to 24 mg)
Number of subjects: 0
Study 7554709 — intervention group
Group type: EXPERIMENTAL
Intervention: Mofegiline (doses up to 48 mg and 24 mg)
Number of subjects: 0
Study 7554709 — intervention group
Group type: EXPERIMENTAL
Intervention: Mofegiline (48 mg single dose and 24 mg multiple daily dose)
Number of subjects: 0
Study 2124210 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.8 g pefloxacin, given orally
Number of subjects: 83
Study 2124210 — intervention group
Group type: COMPARATOR
Intervention: 1.0 g cefotaxime, given intramuscularly
Number of subjects: 83
Study 6103255 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin (1 IU kg‐1 h‐1) administered intravenously for 3‐5 days during and after operation.
Number of subjects: 95
Study 6103255 — intervention group
Group type: COMPARATOR
Intervention: Control group (no heparin treatment).
Number of subjects: 95
Study 6103255 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin administration.
Number of subjects: 95
Study 31802116 — intervention group
Group type: EXPERIMENTAL
Intervention: Craving for high-fat foods
Number of subjects: 811
Study 31802116 — intervention group
Group type: EXPERIMENTAL
Intervention: Craving for carbohydrates/starches
Number of subjects: 811
Study 31802116 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive restraint of eating
Number of subjects: 811
Study 31802116 — intervention group
Group type: EXPERIMENTAL
Intervention: Disinhibition of eating
Number of subjects: 811
Study 31099859 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-Daily Radiotherapy (TDRT)
Number of subjects: 778
Study 31099859 — intervention group
Group type: COMPARATOR
Intervention: Once-Daily Radiotherapy (ODRT)
Number of subjects: 778
Study 31099859 — intervention group
Group type: COMPARATOR
Intervention: Matched cohort ODRT
Number of subjects: 778
Study 31099859 — intervention group
Group type: EXPERIMENTAL
Intervention: Matched cohort TDRT
Number of subjects: 778
Study 31099859 — intervention group
Group type: COMPARATOR
Intervention: Overall Survival ODRT
Number of subjects: 778
Study 31099859 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall Survival TDRT
Number of subjects: 778
Study 31099859 — intervention group
Group type: EXPERIMENTAL
Intervention: Progression-Free Survival
Number of subjects: 778
Study 29433368 — intervention group
Group type: EXPERIMENTAL
Intervention: Briefing session with observations of a properly performed scenario
Number of subjects: 0
Study 29433368 — intervention group
Group type: COMPARATOR
Intervention: Briefing session without observations of a properly performed scenario
Number of subjects: 0
Study 26785745 — intervention group
Group type: EXPERIMENTAL
Intervention: Preemptive kidney transplantation
Number of subjects: 390
Study 26785745 — intervention group
Group type: COMPARATOR
Intervention: Dialysis for less than 36 months
Number of subjects: 390
Study 24065172 — intervention group
Group type: EXPERIMENTAL
Intervention: Varus knee brace
Number of subjects: 20
Study 24065172 — intervention group
Group type: EXPERIMENTAL
Intervention: Valgus knee brace
Number of subjects: 20
Study 24065172 — intervention group
Group type: COMPARATOR
Intervention: No brace
Number of subjects: 20
Study 23029859 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasingly authentic instructional formats
Number of subjects: 0
Study 23029859 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-group assignment
Number of subjects: 0
Study 23029859 — intervention group
Group type: EXPERIMENTAL
Intervention: Teacher training
Number of subjects: 0
Study 20234886 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxidized surface implant
Number of subjects: 35
Study 20234886 — intervention group
Group type: COMPARATOR
Intervention: Machined surface implant
Number of subjects: 35
Study 17050557 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol/fluticasone propionate combination (SFC)
Number of subjects: 0
Study 17050557 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP)
Number of subjects: 0
Study 15842028 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-session Short Psychodynamic Supportive Psychotherapy + pharmacotherapy
Number of subjects: 0
Study 15842028 — intervention group
Group type: COMPARATOR
Intervention: 16-session Short Psychodynamic Supportive Psychotherapy + pharmacotherapy
Number of subjects: 0
Study 12128042 — intervention group
Group type: EXPERIMENTAL
Intervention: 9-week after-school, small group, activities-based intervention
Number of subjects: 208